Borja Suberviola

Dr. Borja Suberviola


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
FCFrancisco Javier Candel
Francisco Javier Candel
MLMiguel Salavert Lleti
Miguel Salavert Lleti
ÁEÁngel Estella
Ángel Estella
MFMiquel Ferrer
Miquel Ferrer
RFRicard Ferrer
Ricard Ferrer
RZRafael Zaragoza
Rafael Zaragoza
Nosocomial pneumonia, or hospital-acquired pneumonia (HAP), and ventilator-associated pneumonia (VAP) are important health problems worldwide, with both being associated with substantial morbidity and mortality. HAP is currently the main cause of death from nosocomial infection in critically ill patients. Although guidelines for the approach to this infection model are widely implemented in international health systems and clinical teams, information continually emerges that generates debate or requires updating in its management. This scientific manuscript, written by a multidisciplinary team of specialists, reviews the most important issues in the approach to this important infectious respiratory syndrome, and it updates various topics, such as a renewed etiological perspective for updating the use of new molecular platforms or imaging techniques, including the microbiological diagnostic stewardship in different clinical settings and using appropriate rapid techniques on invasive respiratory specimens. It also reviews both Intensive Care Unit admission criteria and those of clinical stability to discharge, as well as those of therapeutic failure and rescue treatment options. An update on antibiotic therapy in the context of bacterial multiresistance, in aerosol inhaled treatment options, oxygen therapy, or ventilatory support, is presented. It also analyzes the out-of-hospital management of nosocomial pneumonia requiring complete antibiotic therapy externally on an outpatient basis, as well as the main factors for readmission and an approach to management in the emergency department. Finally, the main strategies for prevention and prophylactic measures, many of them still controversial, on fragile and vulnerable hosts are reviewed.

2 March 2023 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
JCJOSE PERAL GUTIERREZ DE CEBALLOS
JOSE PERAL GUTIERREZ DE CEBALLOS
ÁEÁngel Estella
Ángel Estella
XNXavier Nuvials
Xavier Nuvials
ALEJANDRO HUGO RODRIGUEZ OVIEDOALEJANDRO HUGO RODRIGUEZ OVIEDO
ALEJANDRO HUGO RODRIGUEZ OVIEDO
ISIratxe Seijas
Iratxe Seijas
RZRafael Zaragoza
Rafael Zaragoza
The aim of this study was to establish practical recommendations for the diagnosis and treatment of influenza-associated invasive aspergillosis (IAPA) based on the available evidence and experience acquired in the management of patients with COVID-19-associated pulmonary aspergillosis (CAPA). The CAPA/IAPA expert group defined 14 areas in which recommendations would be made. To search for evidence, the PICO strategy was used for both CAPA and IAPA in PubMed, using MeSH terms in combination with free text. Based on the results, each expert developed recommendations for two to three areas that they presented to the rest of the group in various meetings in order to reach consensus. As results, the practical recommendations for the management of CAPA/IAPA patients have been grouped into 12 sections. These recommendations are presented for both entities in the following situations: when to suspect fungal infection; what diagnostic methods are useful to diagnose these two entities; what treatment is recommended; what to do in case of resistance; drug interactions or determination of antifungal levels; how to monitor treatment effectiveness; what action to take in the event of treatment failure; the implications of concomitant corticosteroid administration; indications for the combined use of antifungals; when to withdraw treatment; what to do in case of positive cultures for Aspergillus spp. in a patient with severe viral pneumonia or Aspergillus colonization; and how to position antifungal prophylaxis in these patients. Available evidence to support the practical management of CAPA/IAPA patients is very scarce. Accumulated experience acquired in the management of CAPA patients can be very useful for the management of IAPA patients. The expert group presents eminently practical recommendations for the management of CAPA/IAPA patients.

Verified
Journal Article
Open access
PDF file
EPElisabeth Papiol
Elisabeth Papiol
RFRicard Ferrer
Ricard Ferrer
Juan Carlos RodríguezJuan Carlos Rodríguez
Juan Carlos Rodríguez
EDEmili Diaz
Emili Diaz
RZRafael Zaragoza
Rafael Zaragoza
ALEJANDRO HUGO RODRIGUEZ OVIEDOALEJANDRO HUGO RODRIGUEZ OVIEDO
ALEJANDRO HUGO RODRIGUEZ OVIEDO
Background/Objectives: The SARS-CoV-2 and influenza A (H1N1)pdm09 pandemics have resulted in high numbers of ICU admissions, with high mortality. Identifying risk factors for ICU mortality at the time of admission can help optimize clinical decision making. However, the risk factors identified may differ, depending on the type of analysis used. Our aim is to compare the risk factors and performance of a linear model (multivariable logistic regression, GLM) with a non-linear model (random forest, RF) in a large national cohort. Methods: A retrospective analysis was performed on a multicenter database including 8902 critically ill patients with influenza A (H1N1)pdm09 or COVID-19 admitted to 184 Spanish ICUs. Demographic, clinical, laboratory, and microbiological data from the first 24 h were used. Prediction models were built using GLM and RF. The performance of the GLM was evaluated by area under the ROC curve (AUC), precision, sensitivity, and specificity, while the RF by out-of-bag (OOB) error and accuracy. In addition, in the RF, the im-portance of the variables in terms of accuracy reduction (AR) and Gini index reduction (GI) was determined. Results: Overall mortality in the ICU was 25.8%. Model performance was similar, with AUC = 76% for GLM, and AUC = 75.6% for RF. GLM identified 17 independent risk factors, while RF identified 19 for AR and 23 for GI. Thirteen variables were found to be important in both models. Laboratory variables such as procalcitonin, white blood cells, lactate, or D-dimer levels were not significant in GLM but were significant in RF. On the contrary, acute kidney injury and the presence of Acinetobacter spp. were important variables in the GLM but not in the RF. Conclusions: Although the performance of linear and non-linear models was similar, different risk factors were determined, depending on the model used. This alerts clinicians to the limitations and usefulness of studies limited to a single type of model.

14 October 2024 in Antibiotics
Verified
Journal Article
Open access
PDF file
ALEJANDRO HUGO RODRIGUEZ OVIEDOALEJANDRO HUGO RODRIGUEZ OVIEDO
ALEJANDRO HUGO RODRIGUEZ OVIEDO
JGJosep Gómez
Josep Gómez
Ignacio Martin-LoechesIgnacio Martin-Loeches
Ignacio Martin-Loeches
LCLAURA CLAVERIAS CABRERA
LAURA CLAVERIAS CABRERA
EDEmili Diaz
Emili Diaz
MBMaría Bodí
María Bodí
Background: Bacterial/fungal coinfections (COIs) are associated with antibiotic overuse, poor outcomes such as prolonged ICU stay, and increased mortality. Our aim was to develop machine learning-based predictive models to identify respiratory bacterial or fungal coinfections upon ICU admission. Methods: We conducted a secondary analysis of two prospective multicenter cohort studies with confirmed influenza A (H1N1)pdm09 and COVID-19. Multiple logistic regression (MLR) and random forest (RF) were used to identify factors associated with BFC in the overall population and in each subgroup (influenza and COVID-19). The performance of these models was assessed by the area under the ROC curve (AUC) and out-of-bag (OOB) methods for MLR and RF, respectively. Results: Of the 8902 patients, 41.6% had influenza and 58.4% had SARS-CoV-2 infection. The median age was 60 years, 66% were male, and the crude ICU mortality was 25%. BFC was observed in 14.2% of patients. Overall, the predictive models showed modest performances, with an AUC of 0.68 (MLR) and OOB 36.9% (RF). Specific models did not show improved performance. However, age, procalcitonin, CRP, APACHE II, SOFA, and shock were factors associated with BFC in most models. Conclusions: Machine learning models do not adequately predict the presence of co-infection in critically ill patients with pandemic virus infection. However, the presence of factors such as advanced age, elevated procalcitonin or CPR, and high severity of illness should alert clinicians to the need to rule out this complication on admission to the ICU.

24 October 2022 in Revista Española de Quimioterapia
Verified
Journal Article
Open access
BSBorja Suberviola
Borja Suberviola
EFElena Cuenca Fito
Elena Cuenca Fito
In response to SARS-CoV-2 infection, the immune system physiologically upregulates to try to clear the virus from the body; failure to compensate for this inflammatory response with an anti-inflammatory response leads to dysregulation of the immune system that ultimately leads to a situation of uncontrolled hyperinflammation called cytokine storm. This cytokine storm can cause ARDS or multi-organ failure leading to patient death. This review exposes the different mechanisms of the inflammatory response in COVID-19 infection and the therapeutic options to treat this process.

26 May 2026 in Medicina Intensiva (English Edition)
Verified
Journal Article
Closed access
VCViviana Chediack
Viviana Chediack
MCMario Calvo
Mario Calvo
ECEleonora Cunto
Eleonora Cunto
ASArnoldo Santos
Arnoldo Santos
ARAlejandro Rodríguez
Alejandro Rodríguez
BSBorja Suberviola
Borja Suberviola